Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-48,425
Closed -$3.66M 695
2026
Q1
$3.66M Buy
48,425
+8,257
+21% +$621K 0.02% 333
2025
Q4
$2.99M Sell
40,168
-8,566
-18% -$626K 0.01% 383
2025
Q3
$3.29M Sell
48,734
-534
-1% -$35.4K 0.01% 374
2025
Q2
$3.21M Buy
49,268
+565
+1% +$33.9K 0.01% 323
2025
Q1
$3.01M Buy
48,703
+8,878
+22% +$588K 0.02% 316
2024
Q4
$2.87M Buy
39,825
+32,303
+429% +$2.52M 0.01% 334
2024
Q3
$613K Sell
7,522
-134
-2% -$10.7K ﹤0.01% 609
2024
Q2
$568K Buy
+7,656
New +$574K ﹤0.01% 619
2023
Q4
Sell
-40,476
Closed -$2.81M 750
2023
Q3
$2.81M Sell
40,476
-3,701
-8% -$280K 0.02% 425
2023
Q2
$3.58M Buy
44,177
+1,168
+3% +$95.4K 0.03% 355
2023
Q1
$3.47M Buy
+43,009
New +$3.46M 0.02% 342

Other funds holding HOLX

AGF Management's HOLX Position: Q2 2026 in Review

AGF Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 48,425 shares — an estimated $3.66M sold.

AGF Management first reported a position in HOLX in Q1 2023 and held it in 11 quarters. The position peaked at $3.66M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • AGF Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • AGF Management sold 48,425 Hologic shares in Q2 2026, an estimated $3.66M.
  • AGF Management first reported a position in Hologic in Q1 2023 and held it in 11 quarters.
  • AGF Management's Hologic position peaked at $3.66M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.